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Abstract
Introduction: Children presenting for the first time with inflammatory bowel disease (IBD) offer a unique opportunity to
study aetiological agents before the confounders of treatment. Microaerophilic bacteria can exploit the ecological niche of
the intestinal epithelium; Helicobacter and Campylobacter are previously implicated in IBD pathogenesis. We set out to study
these and other microaerophilic bacteria in de-novo paediatric IBD.
Patients and Methods: 100 children undergoing colonoscopy were recruited including 44 treatment naı¨ve de-novo IBD
patients and 42 with normal colons. Colonic biopsies were subjected to microaerophilic culture with Gram-negative isolates
then identified by sequencing. Biopsies were also PCR screened for the specific microaerophilic bacterial groups:
Helicobacteraceae, Campylobacteraceae and Sutterella wadsworthensis.
Results: 129 Gram-negative microaerophilic bacterial isolates were identified from 10 genera. The most frequently cultured
was S. wadsworthensis (32 distinct isolates). Unusual Campylobacter were isolated from 8 subjects (including 3 C. concisus, 1
C. curvus, 1 C. lari, 1 C. rectus, 3 C. showae). No Helicobacter were cultured. When comparing IBD vs. normal colon control by
PCR the prevalence figures were not significantly different (Helicobacter 11% vs. 12%, p = 1.00; Campylobacter 75% vs. 76%,
p = 1.00; S. wadsworthensis 82% vs. 71%, p = 0.312).
Conclusions: This study offers a comprehensive overview of the microaerophilic microbiota of the paediatric colon
including at IBD onset. Campylobacter appear to be surprisingly common, are not more strongly associated with IBD and
can be isolated from around 8% of paediatric colonic biopsies. S. wadsworthensis appears to be a common commensal.
Helicobacter species are relatively rare in the paediatric colon.
Trial Registration: This study is publically registered on the United Kingdom Clinical Research Network Portfolio (9633).
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Introduction
Paediatric inflammatory bowel disease (IBD) represents a
variant phenotype characterised by more extensive disease activity
at onset and a progressive course [1]. Immunological differences
can be identified between paediatric and adult Crohn’s disease
(CD) [2]. While paediatric disease represents a distinct phenotype
of IBD, it is surprisingly not explained by a significantly different
genotype [3]. One implication might be that the paediatric
phenotype is an expression of different environmental triggers
rather than inherited factors. Recent studies showing a rise in the
incidence of IBD in childhood and, perhaps more worryingly, a
younger age at onset in those affected support an urgent need for
aetiological studies to explain these trends [4–7]. The discovery
that the use of antibiotics early in life and in multiple courses
confers an increased risk of subsequent IBD development
demonstrates the importance of microbial perturbation in disease
development [8,9]. Recent genetic discoveries reinforce the
essential role for host defence against infection in IBD pathogen-
esis [10].
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The biological importance of the gastrointestinal microbiota
and its symbiotic relationship with the human host is now firmly
established [11,12]. It is increasingly clear that disturbance of the
resident microbiota can induce human disease, with the most
studied example being the ‘‘dysbiosis’’ of IBD and its resultant
inflammation [13,14]. The route from health to IBD through
dysbiosis is unclear but may involve a trigger event such as
bacterial infection [15,16]. We recently postulated that Proteo-
bacteria with adherent and invasive properties may exploit
weaknesses in host defences to drive this dysbiotic change [16].
Helicobacter species (microaerophilic members of the Epsilonpro-
teobacteria; ‘‘microaerophilic’’ describing bacteria that thrive in
low oxygen concentrations) have been shown to initiate IBD in
both rodent and primate models and may also be implicated in
infectious proctitis in humans [17]. Conflicting evidence exists
from human studies to support Helicobacter as agents in human IBD
[18–26]; nevertheless the compelling animal data has made the
genus worthy of consideration as a potential pathogen in IBD.
Campylobacter concisus (another microaerophilic Epsilonproteobac-
terium) was cultured from mucosal biopsies from a paediatric CD
patient by Zhang et al [27]. This organism has since been shown to
be more prevalent in IBD and to be capable of adhering to and
invading epithelial cells and driving a pro-inflammatory change
[28–31].
Much of the current literature on IBD microbiology utilises
convenient cohorts of patients with established disease, potentially
introducing major confounders when interpreting results [32].
Paediatric IBD offers an opportunity to explore these problems,
since children are relatively free of additional significant co-
morbidities and are generally treatment naı¨ve at IBD diagnosis.
For these reasons we set up the ‘‘Bacteria in Inflammatory bowel
disease in Scottish Children Undergoing Investigation before
Treatment’’ (BISCUIT) study, with the specific aims of:
1) Recruiting a robustly described, prospective clinical cohort of
newly presenting children with untreated IBD alongside
children with normal colons as controls
2) Isolating and identifying microaerophilic bacteria (particu-
larly Helicobacter and Campylobacter) that may be of clinical
relevance at the onset of IBD
3) Confirming the true prevalence of specific microaerophilic
organisms within the colonic mucosa by molecular methods.
The BISCUIT study recruited 100 Scottish children over a 30
month period. The data contained within this paper documents
the isolation and identification of microaerophilic bacteria
alongside the molecular (true) prevalence of Helicobacter and
Campylobacter species and Sutterella wadsworthensis within colonic
biopsies from the entire BISCUIT cohort. In a complementary but
distinct analysis we previously published a full hypothesis-free
bacterial diversity assessment using pyrosequencing on a subset of
the cohort (37 BISCUIT subjects in total) [32].
Methods
Patients were recruited to the BISCUIT study from elective
colonoscopy lists in three paediatric centres (Royal Aberdeen
Children’s Hospital, Aberdeen; Royal Hospital for Sick Children,
Glasgow and Ninewells Hospital, Dundee). An approach with
study information was made either on the day of admission (the
day before endoscopy) or by post in advance of admission. Patients
were excluded if they received systemic antibiotics or steroids 3
months prior to their colonoscopy, immunosuppression at any
time, or if they had a previous IBD diagnosis. IBD investigations
were as per the Porto criteria. IBD diagnosis and phenotype were
assigned with reference to the Lennard-Jones, Montreal and Paris
criteria (Table S2) [33–36]. Comprehensive clinical data were also
collected at recruitment by a single investigator through use of a
standardised verbal questionnaire.
Initial recruitment was into two macroscopically-defined cate-
gories, those with likely IBD, at first presentation, with macro-
scopic colonic inflammation and those undergoing colonoscopy
who subsequently had a normal colon macroscopically. Final
diagnosis and disease categorisation was assigned once endoscopic,
histological and radiological investigations were complete after a
minimum of six months follow-up.
Ethics Statement
Ethical approval was granted by North of Scotland Research
Ethics Service (09/S0802/24) on behalf of all participating centres
and written informed consent was obtained from the parents of all
subjects. Informed assent was also obtained from older children
who were deemed capable of understanding the nature of the
study.
This study is publically registered on the United Kingdom
Clinical Research Network Portfolio (9633).
Biopsies were taken from a single site, from the distal colon in
controls (rectum/sigmoid) or from the most distal inflamed site in
those with colonic inflammation. 5–6 biopsies were collected using
standard endoscopic forceps from all recruits. 1–2 biopsies were
used for microaerophilic culture work by transferring these
biopsies immediately into individual 2 ml screw-top containers
with ,700 ml Brucella broth which were incubated at room
temperature until plated. 2–3 biopsies were collected for DNA
analysis into a sterile 1.5 ml Eppendorf container and placed
immediately onto ice before transfer to 280uC storage. The
remaining biopsy was collected in paraformaldehyde for future
fluorescent in-situ hybridisation studies.
Culture work was performed as described in Mukhopadhya et al
[37] utilising five selective plates and one plain blood agar plate,
each incubated in microaerophilic gas conditions generated by
Figure 1. Recruitment flowchart of recruits to BISCUIT study.
Those where recruitment was not possible were approached by post
but could not then be recruited on their day of colonoscopy. The one
child consented but not biopsied was due to unavailability of the
investigator on the day in question.
doi:10.1371/journal.pone.0058825.g001
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AnoxomatH (MartH Microbiology, Drachten, Netherlands) and
reviewed twice weekly for up to one month. Gram-negative and
oxygen sensitive (by virtue of failed subculture in room air)
bacterial isolates were identified by sequencing of the 16S rRNA
gene. A minimum read length of 400 bp was obtained for
attributing bacterial identities, the result of which was searched
against the NCBI BLAST database (http://blast.ncbi.nlm.nih.
gov/Blast.cgi).
DNA extraction of mucosal biopsies was performed using the
commercially available Qiagen QIAamp Mini kit (Qiagen,
Crawley, UK) with minor modifications as described previously
[25]. A test polymerase chain reaction (PCR) with biopsy DNA
was performed utilising universal bacterial primers to confirm the
suitability of the DNA for further analysis (Table S1) [38].
Conventional PCR was undertaken to determine the prevalence of
Helicobacter genus, Campylobacter genus and Sutterella wadsworthensis
using primers and conditions described previously (Table S1)
[25,30,37]. PCR products from Helicobacter and Campylobacter genus
reactions were either directly sequenced on an Applied Biosystems
model 3730 automated capillary DNA sequencer or cloned first
into JM109 competent cells with pGEM-T-easy vector if sequence
analyses indicated a mixed sequencing profile [30].
Helicobacter pylori serology was performed using the Premier H.
pylori enzyme immunoassay which detects IgG antibody (Meridian
Bioscience).
All statistical comparisons were undertaken using SPSS
Statistics version 20 (IBM Software 2010).
Results
128 Scottish children were approached for the study with 100
being recruited (Figure 1). Final categorisation was based on a
thorough review of macroscopic, microscopic and available
radiological data and is presented in Table 1 and Table 2
alongside categorical, demographic and numerical clinical data
respectively. 44 IBD subjects were diagnosed as CD (29),
ulcerative colitis (UC) (13) and IBD-type unclassified (IBD-U)
(2). Individual IBD phenotypes are shown in Table S2.
Granulomata were identified in at least one biopsy site in 21 of
29 (72.4%) CD recruits. A priori, the intention was to compare
IBD recruits against those with a normal colon, however in order
to achieve this, those with microscopic pathology were further sub-
categorised. ‘‘Normal colon control’’ subjects had both a
macroscopically and microscopically normal colon. ‘‘Eosinophilic
controls’’ had histologically significant eosinophilic infiltration of
their colonic mucosa in at least one site. ‘‘Non-specific inflamed,
non-IBD’’ subjects had microscopic evidence of inflammation but
insufficient grounds for an IBD diagnosis. The single ‘‘proto-IBD’’
recruit would have been classified within the ‘‘eosinophilic
control’’ category but has since been re-evaluated and has
subsequently developed CD. Data from each of these latter three
phenotypic groups are presented in full; however statistical
analyses compare the IBD and normal colon control groupings
only.
Comparisons of clinical data are shown in Table 1 and
Table 2. Histological gastritis was more common in the IBD
cohort than normal colon controls who underwent gastroscopy
(p,0.001; Table 1). Conversely, histological identification of H.
pylori was higher in the normal colon controls and absent in the
IBD cohort (p = 0.035; Table 1).
Of 555 attempted bacterial subcultures, 494 demonstrated some
growth within 7 days, with 414 yielding sufficient growth to allow
Gram-staining and aerobic subculture challenge to be completed
(Figure 2). 129 bacterial isolates met the requirements for further
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identification (Gram-negative but failed aerobic subculture). Of
these, 114 yielded sufficient growth for DNA based identification.
112 were confirmed as Gram-negative microaerophilic bacteria
after formal sequence identification. The formal identities of these
112, including 73 distinct patient isolates, are presented in
Table 3. The identities of the remaining two isolates matched
two separate Gram-positive species (Bifidobacterium longum and
Enterococcus faecalis) hence they were removed.
PCR prevalence data and Helicobacter pylori serology results for
each of the phenotypic categories are shown in Table 4 and for
each of the subjects in Table S2. There was no significant
difference in PCR prevalence for Helicobacter, Campylobacter or
Sutterella wadsworthensis between the IBD cohort and normal colon
controls (Table 4). No H. pylori seropositive subject was positive for
Helicobacter PCR and vice-versa. Table 5 documents Campylobacter
PCR sequencing data to species-level stratified by clinical
phenotype. It is apparent from the data that individuals can
Figure 2. Basic phenotypic assessment of 414 bacterial isolates
obtained from the paediatric colonic mucosa. 129 were both
Gram-negative and non-aerobic, of which 114 were formally identified
by sequencing.
doi:10.1371/journal.pone.0058825.g002
Table 3. Bacterial Isolates Identified based on 16S rDNA sequencing.
Isolate
Number of Subcultures
Obtained (May include
duplicates from same patient
derived from
different growth media)
Distinct
Patient
Isolates Source
16S
Sequence
Length
Percentage
Similarity
on BLAST
Alistipes finegoldii 1 1 IBD-type unspecified 515 bp 100%
Bacteroides caccae 3 2 Non-specific inflamed
non-IBD (1), IBD-type
unspecified (1)
513–795 bp 99%
Bacteroides dorei 1 1 Normal colon control 684 bp 100%
Bacteroides fragilis 1 1 Crohn’s disease 526 bp 99%
Bacteroides nordii 1 1 Normal colon control 566 bp 99%
Bacteroides ovatus 2 2 Normal colon control (2) 433 bp 99%
Bacteroides salyersiae 2 1 IBD-type unspecified (2) 697 bp, 823 bp 99%
Bacteroides thetaiotaomicron 1 1 Crohn’s disease 415 bp 100%
Bacteroides uniformis 1 1 Normal colon control 503 bp 99%
Butyricimonas virosa 2 2 Normal colon control (1), IBD-type
unspecified (1)
569 bp, 676 bp 98–99%
Campylobacter concisus 6 3 Crohn’s disease (2), Ulcerative colitis (1) 1357–1423 bp 99–100%
Campylobacter curvus 1 1 Normal colon control 1537 bp 99%
Campylobacter lari 1 1 Normal colon control 647 bp 100%
Campylobacter rectus 1 1 Normal colon control 401 bp 100%
Campylobacter showae 6 3 Normal colon control (2), Crohn’s disease (1) 1325–1422 bp 99%
Eikenella corrodens 2 1 Crohn’s disease 776–802 bp 99–100%
Haemophilus parainfluenzae 8 7 Crohn’s disease (3), Ulcerative colitis (2),
Normal colon control (2)
455–807 bp 99–100%
Odoribacter splanchnicus 1 1 Eosinophilic control 819 bp 99%
Parabacteroides distasonis 7 7 Normal colon control (6),
Ulcerative colitis (1)
412–786 bp 99%
Sutterella wadsworthensis 61 32 Normal colon control (11), Crohn’s
disease (8), Ulcerative colitis (6),
Eosinophilic control (3),
Non-specific inflamed non-IBD (2),
IBD-type unspecified (1), Proto-IBD (1)
411–1423 bp 97–100%
Terrahaemophilus
aromaticivorans
3 3 Crohn’s disease (1), Ulcerative
colitis (1), Normal colon control (1)
554 672 bp 99%
Total 112 73
doi:10.1371/journal.pone.0058825.t003
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harbour multiple distinct species. Of the 72 positive subjects, 44
had a single Campylobacter identified with two species being
identified in 17 and three species in the remaining 11 (Table 6).
Campylobacter curvus, Campylobacter gracilis and Campylobacter ureolyticus
were never identified in isolation. The Helicobacter sequencing data
was far less complex with only 12 subjects yielding positive PCR
product. Of these, 5 were from normal colon controls, 5 from IBD
(4 CD, 1 UC) and 2 were from eosinophilic controls. After
sequencing the PCR product, 8 of the 12 (4 normal colon controls,
2 IBD- both CD, 2 eosinophilic controls) were identified as
Wolinella succinogenes, another Epsilonproteobacteria and member
of the Helicobacteraceae. The four remaining Helicobacter positive
results were not identifiable by direct sequencing and underwent
cloning and sequencing analysis. This revealed the presence of
both W. succinogenes and Helicobacter brantae (from a CD patient) and
confirmed the presence of Helicobacter hepaticus from a second CD
patient. The two remaining patient samples remained unidenti-
fiable despite repeated cloning attempts.
Discussion
This study comprehensively describes the microaerophilic
microbiota of the paediatric colon with specific reference to
untreated, new-onset paediatric IBD and also those with a normal
colon. Our main findings are of a high molecular prevalence and
culture recovery rate of unusual Campylobacter species and S.
wadsworthensis and of a low molecular prevalence of Helicobacter-
aceae. There was no difference in the prevalence of microaero-
philic species between IBD patients and controls. We acknowledge
that the microaerophilic microbiota comprises a relatively small
proportion of the bacterial community present within the colon,
with the majority of species being obligate anaerobes. Evidence
supporting a role for these microaerophilic species in IBD cannot
however be ignored and they are therefore worthy of targeted
study.
The possibility that Helicobacter species may be involved in IBD
pathogenesis is an intriguing one that has been the subject of many
studies and much debate [17–26]. The earliest observation that H.
pylori seropositivity is negatively associated with IBD [39] was not
directly replicated in this study, however in our recruits
undergoing concurrent upper gastrointestinal endoscopy, micro-
scopic evidence of H. pylori was entirely absent from the IBD
cohort and significantly higher in normal colon controls. C. concisus
is an organism that has generated significant interest following
culture recovery from the colon of children with CD, with
subsequent work describing the adherent, invasive and pro-
inflammatory capabilities of the organism [27,29]. Other authors
have suggested that the organism may be increased in IBD against
controls [28,30,31], yet our data contradicts this finding by
demonstrating a comparable prevalence between the two group-
ings. Our data are the first to specifically address these organisms
at the onset of IBD. The low prevalence of Helicobacteraceae and
equivalent prevalence of C. concisus at the onset of IBD which we
have shown makes it unlikely that these organisms have a role in
disease pathogenesis in children; nevertheless their identification in
the colon of subjects with established disease in other studies
suggests that roles within disease chronicity may still be possible.
We have described a surprisingly diverse and prevalent
colonisation of the paediatric colon with unusual Campylobacter
species, including the possibility of up to three distinct species co-
existing in close proximity in the same individual. The importance
of these Campylobacter in paediatric health and disease warrants
further consideration, particularly given the unquestionable
pathogenicity of Campylobacter jejuni and Campylobacter coli, the two
most commonly identified representatives of the genus in
paediatric faecal samples [40]. Our data suggest a more diverse
and prevalent colonic colonisation with Campylobacter species than
previously reported. This finding may be a direct reflection of the
sampling bias introduced by studying faeces alone which is known
to represent a distinct ecosystem [41]. We have shown that
unusual Campylobacter species can be identified in the colon of 7/10
children and cultured successfully from 8/100. Additional studies
are required to increase the culture yield for these organisms and
to characterise individual species and further outline their role in
health and disease.
Sutterella wadsworthensis is an organism that has rarely been
discussed in the literature, having first been described as a
potential gastrointestinal pathogen in 1996 [42]. We recently
examined the molecular prevalence of this organism in an adult
study including those with UC and those with a normal colon and
Table 4. PCR Prevalence and Helicobacter pylori Serology Data from BISCUIT Study.
Helicobacter pylori
Serology Positive
Helicobacter Genus
PCR Positive
Campylobacter Genus
PCR Positive
Sutterella wadsworthensis
PCR Positive
Total
Subjects
IBD 1 (2.3%) 5 (11.4%) 33 (75.0%) 36 (81.8%) 44
(Crohn’s disease) 0 (0%) 4 (13.8%) 22 (75.9%) 23 (79.3%) 29
(Ulcerative colitis) 1 (7.7%) 1 (7.7%) 9 (69.2%) 11 (84.6%) 13
(IBD-type unspecified) 0 (0%) 0 (0%) 2 (100%) 2 (100%) 2
Normal colon control 6 (14.3%) 5 (11.9%) 32 (76.2%) 30 (71.4%) 42
Eosinophilic control 1 (14.3%) 2 (28.6%) 4 (57.1%) 7 (100%) 7
Non-specific inflamed non-IBD 0 (0%) 0 (0%) 3 (50.0%) 5 (83.3%) 6
Proto-IBD 0 (0%) 0 (0%) 0 (0%) 1 (100%) 1
Total 8 (8.0%) 12 (12.0%) 72 (72.0%) 79 (79.0%) 100
IBD vs. Normal colon control by Fisher’s
exact test (2-sided, n = 86)
p = 0.055 p = 1.00 p = 1.00 p = 0.312
doi:10.1371/journal.pone.0058825.t004
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found a similar and high prevalence in both groups [37].
Phenotypic and genotypic comparison of isolates suggested no
difference between the two clinical groups. We suggested therefore
that S. wadsworthensis is likely a common intestinal commensal. A
recent paper on 32 children has however linked S. wadsworthensis to
autism [43], generating considerable discussion in the process
[44,45]. We again find within the paediatric population, that this
organism is commonly identified and easily recovered from
biopsies by culture. Given the high prevalence (79% overall) of
this organism in our whole cohort, we consider it unlikely that it is
specific to the autistic intestine as has been suggested. This of
course does not exclude differential immunological reaction to the
organism within autistic children, which requires further explora-
tion.
The limitations of this study cohort have been discussed
previously [32] and will be repeated here briefly. All subjects
received stimulant bowel preparation before colonoscopy. Al-
though this may have altered the bacteria within the colonic
mucosa, the treatment was given to all and would likely act
equivalently between groups. A study where children undergo
colonoscopy under general anaesthetic without bowel preparation
would be unethical. The controls in this study were all children
undergoing colonoscopy for gastrointestinal symptoms. There
were therefore no strictly ‘‘healthy’’ controls. We have tried to
address this by describing our subcategorisation of recruits in detail
and selecting only those with a macroscopically and microscop-
ically normal colon as our main control group.
This study rejects a role for the microaerophilic bacteria
Helicobacter, Campylobacter and S. wadsworthensis at the initiation of
paediatric IBD, however hypothesis-free analysis of a subgroup of
the same study using pyrosequencing has shown that differences in
the IBD microbiota are apparent at the onset of disease. Of
particular interest to the culture results from this study, we have
shown that Parabacteroides appear to be significantly reduced in UC
against normal colon controls [32]. This appears to be reflected
further in our culture recovery rate of Parabacteroides distasonis
reported here (6 isolates derived from normal colon controls
against a single UC isolate). This observation would fit with the
discoveries that P. distasonis antigens can attenuate murine colitis
and are specifically recognised by colonic T regulatory cells
[46,47]. P. distasonis might be suitable for consideration as a
probiotic bacterium for topical colonic treatment in UC.
Conclusion
This study has provided novel data describing a hitherto
unrecognised high prevalence and diversity of unusual Campylobacter
species and a high prevalence of S. wadsworthensis in the paediatric
colon. We have also shown a low prevalence of organisms within the
Helicobacteraceae. Although we have not demonstrated any
organisms of likely significance to IBD pathogenesis, we have
exploredtwolikelycandidategeneraspecificallyat theonsetofdisease
and demonstrated that their involvement in disease initiation is
unlikely. Our data on S. wadsworthensis refutes the suggestion that this
organism is specific to the paediatric autistic intestine, and alongside
our previous work, suggests this organism is a common intestinal
commensal. Our isolates of P. distasonis from the normal paediatric
colon might be suitable for consideration as probiotics. We have
shown that a targeted culture and molecular microbiology study in
thepaediatricpopulationcandemonstrate surprisingresultsandoffer
a high yield for the enumeration of unusual and rarely described
organisms.
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